The NGS-PTL Advisory Board is composed by outstanding scientists with skills and expertise in the biological and clinical research on hematological diseases, in the care of leukemia patients, in the fields of human genetics, genomics and transcriptomics, as well as of bioinformatics and biostatistics.
The Advisory Board will act with a consultancy and advisory function, being part of the NGS-PTL strategy orienting the RTD activities toward the real needs related to the project issues. It will also offer scientific and strategic advice to the consortium to ensure that all messages are consistent, scientifically sound and evidence based.
At the moment, the Advisory Board is composed by Prof. Rüdiger Hehlmann (Mannheim Medical Faculty, University of Heidelberg, Germany) and Prof. Tiziana Storlazzi (Department of Biology, University of Bari, Italy). However, further members will be integrated on the basis of suggestions provided by the NGS-PTL Consortium partners during the project implementation.